TITLE

Changes of IL-1, TNF-Alpha, IL-12 and IL-10 Levels with Chronic Liver Failure

AUTHOR(S)
Guowang Liu; Kecheng Tang; Qian Li Guiyu Yuan; Wukui Cao; Wei Lu
PUB. DATE
April 2011
SOURCE
Surgical Science;Apr2011, Vol. 2 Issue 2, p69
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: To investigate the action of cytokines in patients with chronic liver failure and to explore the roles of cytokines in chronic liver failure. Methods: Thirty-one patients with chronic liver failure admitted from May 2006 to November 2009 were included. Thirty cases with mild to moderate chronic type B hepatitis admitted concomitantly were regarded as control. IL-1, TNF-alpha, IL-12, IL-10 Levels in serum was the factors to determine at clinical diagnosis and 2-week treatment. We analyzed levels of cytokines action in 31 chronic liver failure patients both at clinical diagnosis and 2-week treatment in comparison with control group. Results: We analyzed IL-1 level in death group at clinical diagnosis and 2-week treatment were significant higher than in survival and control groups, furthermore it was also higher in survival group than in control group. At clinical diagnosis, TNF-alpha level in death group was higher than that in control. However, there was no obviously difference between the death group and the survival group in TNF-alpha level. With the progression of the disease, TNF-alpha level was remarkably risen in death group, but decreased in survival group. IL-10 level was dramatically increased in death group, but no changed in survival group. IL-12 level in death group was higher than in survival group, but lower than in control group. Conclusions: The levels of TNF-alpha, IL-1, IL-10 and IL-12 in patients with chronic liver failure was increased and the increase of IL-10 is secondary to elevation of IL-12.
ACCESSION #
71981851

 

Related Articles

  • Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. Qinghong Wang; Yanhua Zheng; Zemin Huang; Yi Tian; Jijun Zhou; Qing Mao; Yuzhang Wu; Bing Ni // BMC Immunology;2011, Vol. 12 Issue 1, p25 

    Background: Foxp3 protein plays a critical role in mediating the inflammatory response and can inhibit the proinflammatory IL-23/IL-17 pathway. However, the molecular interplay of Foxp3 and the IL-23/IL-17 pathway in patients with chronic hepatitis B (CHB) remains unclear. To this end, we...

  • Association between Plasma Fibrinogen Levels and Mortality in Acute-on-Chronic Hepatitis B Liver Failure. Shao, Zhexin; Zhao, Ying; Feng, Limin; Feng, Guofang; Zhang, Juanwen; Zhang, Jie // Disease Markers;4/16/2015, p1 

    Acute-on-chronic liver failure (AoCLF) is the most common type of liver failure and is associated with high mortality. Fibrinogen is critical in maintaining primary and secondary hemostasis. Therefore, we prospectively analyzed the association between fibrinogen and outcomes in AoCLF patients....

  • Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China. Wei Min Ke; Xue Jun Li; Li-Na Yu; Jing Lai; Li, Xiao He; Zhi Liang Gao; Pei Jia Chen // Journal of Gastroenterology;Apr2006, Vol. 41 Issue 4, p347 

    Background. The purpose of this study was to clarify the relationships between patients who had fatal liver failure during the course of chronic hepatitis B and those who were also superinfected with hepatitis A, C, D, or E virus, as well as their hepatitis B virus e system status, so that...

  • Lamivudine is effective against hepatitis B virus reactivation even during fulminant liver failure. Lee, W.-C.; Wu, M.-J.; Cheng, C.-H. // Kidney;Jul/Aug2002, Vol. 11 Issue 4, p182 

    Deals with a study which elucidated the effectiveness of lamivudine for hepatitis B virus reactivation with or without fulminant hepatic failure in renal transplant recipients. Methodology used in the study; Results and conclusion.

  • Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. Miyake, Yasuhiro; Iwasaki, Yoshiaki; Terada, Ryo; Takaguchi, Kouichi; Sakaguchi, Kohsaku; Shiratori, Yasushi // Journal of Gastroenterology;Jun2007, Vol. 42 Issue 6, p485 

    Hepatitis B virus infection is the most frequent cause of fulminant hepatic failure. Recently, systemic inflammatory response syndrome has been reported to be important in patients with fulminant hepatic failure. However, prognostic factors for fulminant hepatitis B have not been fully examined....

  • Lamivudine withdrawal.  // Reactions Weekly;3/25/2006, Issue 1094, p14 

    This article discusses research done on the adverse effect of lamivudine withdrawal. It references a study by J.-M. Zhang and colleagues in the March 2006 issue of the "Journal of Medical Virology." After discontinuing lamivudine, a middle-aged man developed liver failure associated with the...

  • Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. Yang, Sien-Sing; Cheng, Ken-Sheng; Lai, Yung-Chih; Wu, Chi-Hwa; Chen, Tzen-Kwan; Lee, Chia-Long; Chen, Ding-Shinn // Journal of Gastroenterology;2002, Vol. 37 Issue 8, p626 

    Background. We carried out a study to predict the prognosis of acute hepatic failure in patients with chronic hepatitis B. Methods. We studied 25 consecutive patients with severe acute hepatitis. Severe acute hepatitis was defined as the development of acute hepatitis with a total serum...

  • Enhanced Peripheral γδT Cells Cytotoxicity Potential in Patients with HBV-Associated Acute-On-Chronic Liver Failure Might Contribute to the Disease Progression. Chen, Min; Hu, Peng; Peng, Hui; Zeng, Weiqun; Shi, Xiaofeng; Lei, Yu; Hu, Huaidong; Zhang, Dazhi; Ren, Hong // Journal of Clinical Immunology;Aug2012, Vol. 32 Issue 4, p877 

    Background: The current study explored the characteristics of γδ T cells in the blood of HBV-associated acute-on-chronic liver failure (HBV-ACLF) patients and examined the relationship between γδ T cells and the clinical parameters. Methods: Blood samples were obtained from 26...

  • Fibronectin predicts the outcome of acute-on-chronic hepatitis B liver failure. Chen, Yiyi; Shao, Zhexin; Yin, Zhou; Jiang, Zhuxiu // International Health (1876-3413);Jan2015, Vol. 7 Issue 1, p67 

    Background Acute-on-chronic hepatitis B liver failure (ACHBLF) is a serious condition with varied etiologies and manifestations, and is associated with a high mortality rate. Fibronectin is involved in a number of biological processes, including cellular adhesion, motility, differentiation,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics